Literature DB >> 8447499

Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats.

D A Morgan1, T W Balon, B H Ginsberg, A L Mark.   

Abstract

The insulin hypothesis of hypertension proposes that hyperinsulinemia increases sympathetic nerve activity (SNA) and raises arterial pressure. The goals of this study were 1) to determine if hyperinsulinemia produces regionally uniform or nonuniform increases in SNA and 2) to test the hypothesis that spontaneously hypertensive rats (SHR) have exaggerated sympathoadrenal responses to hyperinsulinemia. We measured plasma insulin, blood glucose, mean arterial pressure, and adrenal, renal, and lumbar SNA in alpha-chloralose-anesthetized SHR and normotensive Wistar-Kyoto (WKY) rats before and during infusion of two doses of insulin for 60 min each while maintaining euglycemia. In WKY rats, graded increases in plasma insulin from 27 +/- 5 (SE) to 200 +/- 29 microU/ml increased lumbar SNA from 100% to 285 +/- 26% but failed to significantly increase adrenal or renal SNA. In SHR rats, similar increases in plasma insulin from 27 +/- 4 to 213 +/- 33 microU/ml caused significant increases in adrenal (100% to 174 +/- 16%) and lumbar (100% to 307 +/- 26%) SNA but not in renal SNA. Despite increases in SNA, mean arterial pressure did not increase significantly in either group of rats. We conclude that 1) hyperinsulinemic euglycemic clamp produces regionally nonuniform increases in sympathetic nerve activity, and 2) there is a potentiated increase in adrenal SNA in SHR compared with WKY rats during hyperinsulinemia, whereas lumbar SNA responses were similar in the two strains, and renal SNA did not increase in either strain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447499     DOI: 10.1152/ajpregu.1993.264.2.R423

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

1.  Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.

Authors:  Kamal Rahmouni; Donald A Morgan; Gina M Morgan; Xuebo Liu; Curt D Sigmund; Allyn L Mark; William G Haynes
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 2.  Obesity and adipokines: effects on sympathetic overactivity.

Authors:  Michael M Smith; Christopher T Minson
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

Review 3.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

Review 4.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

Review 5.  Recording sympathetic nerve activity chronically in rats: surgery techniques, assessment of nerve activity, and quantification.

Authors:  Sean D Stocker; Martin S Muntzel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

Review 6.  Body fat and sympathetic nerve activity.

Authors:  U Scherrer; R Owlya; M Lepori
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

7.  Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus.

Authors:  Kathryn R Ward; James F Bardgett; Lawrence Wolfgang; Sean D Stocker
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

8.  Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter.

Authors:  P Valensi; S Chiheb; M Fysekidis
Journal:  Diabetologia       Date:  2013-04-13       Impact factor: 10.122

Review 9.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

10.  Sciatic nerve stimulation induces hypotension but not renal or lumbar sympathoinhibition in hypertensive Dahl rats.

Authors:  M J Kenney; D A Morgan
Journal:  Clin Auton Res       Date:  1993-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.